Literature DB >> 8296641

ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE).

R A Sinico1, C Pozzi, A Radice, A Tincani.   

Abstract

Antibodies to lactoferrin were detected in about 20% of patients with SLE, irrespective of the presence of renal involvement and in 10% of patients with rheumatoid arthritis and in 19% of patients with scleroderma. We conclude that anti-lactoferrin antibodies may be found in different types of connective tissue disease. Their clinical significance in these diseases however remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8296641     DOI: 10.1007/978-1-4757-9182-2_66

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  J A Savige; L Chang; D Wilson; R R Buchanan
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

2.  Anti-neutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus.

Authors:  S N Wong; V Shah; M J Dillon
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

3.  The association between serological biomarkers and primary Sjogren's syndrome associated with peripheral polyneuropathy.

Authors:  Che-Wei Hsu; Yu-Jih Su; Wen-Neng Chang; Nai-Wen Tsai; Wen-Chan Chiu; Ben-Chung Cheng; Chih-Min Su; Chi-Ren Huang; Ya-Ting Chang; Cheng-Hsien Lu
Journal:  Biomed Res Int       Date:  2014-04-13       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.